Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MEF2C | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | CD82 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | LTB4R | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | XG | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | LYSMD1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | PAX7 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PCCA | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | PRCC | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | C1orf94 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | NACA2 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |